-
Article
Open AccessPlatelet-rich plasma therapy in erectile dysfunction and Peyronie’s disease: a systematic review of the literature
Platelet-rich plasma (PRP) as a regenerative therapy has gained interest in the field of andrology for the treatment of erectile dysfunction (ED) and Peyronie’s disease (PD). This systematic review aims to cri...
-
Article
Response to: “Commentary on: phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie’s disease: a retrospective cohort study”
-
Article
Open AccessPhosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie’s Disease: A retrospective cohort study
Treatment with Phosphodiesterase Type 5 inhibitors (PDE5is) has shown promise in managing Peyronie’s disease (PD) during its active phase. In a retrospective cohort study of 133 PD patients, we compared daily ...
-
Article
Quality of information and appropriateness of ChatGPT outputs for urology patients
The proportion of health-related searches on the internet is continuously growing. ChatGPT, a natural language processing (NLP) tool created by OpenAI, has been gaining increasing user attention and can potent...
-
Article
Quality of information and appropriateness of ChatGPT outputs for urology patients
-
Article
Quality and benefits of the erectile dysfunction information on websites, social-media, and applications
Erectile Dysfunction (ED) is defined as the persistent inability to obtain and maintain an erection that enables satisfactory sexual intercourse. ED prevalence vary across age groups, affecting approximately 1...
-
Chapter
Diagnosis of Male Sexual Dysfunction
Sexual behavior is influenced by biology, psychology, interpersonal relationships, and culture. The investigation and diagnosis of sexual dysfunctions require an exploratory and holistic approach where the hea...
